The FDA has finally verified the safety and environmental sustainability of AquaBounty Technologies Inc.’s genetically modified (GM) salmon, after a wait of nearly 20 years. This means that the company’s product, called AquAdvantage Salmon, could soon be available to consumers.
Even after the drawn-out FDA review process, many people remain opposed to what they term “Frankenfish” and are demanding legislative action to ban GM animal products or mandate labeling. These misguided efforts stand in the way of benefits to both consumers and the environment.
The enhanced variety of salmon can grow to the same market size as their wild counterparts twice as fast and with 75 percent less feed. This efficiency, driven by a growth gene that remains turned on, could lower AquaBounty’s carbon footprint 25 times over and result in lower costs for consumers.
Read the full story at Economics21 >>
Read more about GMO salmon >>